Whitener Capital Management, Inc. Amgen Inc Transaction History

Whitener Capital Management, Inc.

$303 Million
Q1 2024

A detailed history of Whitener Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Whitener Capital Management, Inc. holds 6,941 shares of AMGN stock, worth $2.17 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

6,941

Previous 6,903 0.55%

Holding current value

$2.17 Million

Previous $1.99 Million 0.75%

% of portfolio

0.65%

Previous 0.72%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$268.87 - $324.56 $10,217 - $12,333	38 Added 0.55%	6,941 $1.97 Million
Q4 2023 Jan 10, 2024	SELL	$255.7 - $288.46 $3,835 - $4,326	-15 Reduced 0.22%	6,903 $1.99 Million
Q3 2023 Nov 02, 2023	BUY	$218.65 - $271.46 $12,463 - $15,473	57 Added 0.83%	6,918 $1.86 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $21,855 - $25,843	-102 Reduced 1.46%	6,861 $1.52 Million
Q1 2023 Apr 12, 2023	SELL	$225.79 - $275.2 $16,934 - $20,640	-75 Reduced 1.07%	6,963 $1.68 Million

Q4 2022 Mar 01, 2023	BUY	$229.03 - $291.01 $18,093 - $22,989	79 Added 1.14%	7,038 $1.85 Million
Q3 2022 Oct 28, 2022	SELL	$224.46 - $253.15 $50,054 - $56,452	-223 Reduced 3.1%	6,959 $1.57 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $15,918 - $17,715	-69 Reduced 0.95%	7,182 $1.75 Million
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $12,059 - $13,341	55 Added 0.76%	7,251 $1.75 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $1.43 Million - $1.64 Million	7,196 New	7,196 $1.62 Million
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $1.17 Million - $1.34 Million	-5,900 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $50,520 - $59,190	-238 Reduced 3.88%	5,900 $1.36 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $55,592 - $61,675	238 Added 4.03%	6,138 $1.5 Million
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $454,830 - $541,622	-2,102 Reduced 26.27%	5,900 $1.36 Million
Q3 2020 Oct 09, 2020	SELL	$234.65 - $260.95 $168,948 - $187,884	-720 Reduced 8.25%	8,002 $2.03 Million
Q2 2020 Jul 17, 2020	BUY	$197.81 - $242.74 $9,890 - $12,137	50 Added 0.58%	8,722 $2.06 Million
Q1 2020 Apr 24, 2020	SELL	$182.24 - $241.7 $31,709 - $42,055	-174 Reduced 1.97%	8,672 $1.76 Million
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $23,678 - $28,372	-136 Reduced 1.51%	8,846 $1.71 Million
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $435,086 - $510,020	2,610 Added 40.96%	8,982 $1.66 Million
Q1 2019 May 02, 2019	SELL	$180.87 - $203.88 $333,705 - $376,158	-1,845 Reduced 22.45%	6,372 $1.21 Million
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $358,584 - $418,582	2,010 Added 32.38%	8,217 $1.6 Million
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $55,957 - $63,084	302 Added 5.11%	6,207 $1.29 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $6,974 - $7,833	42 Added 0.72%	5,905 $1.09 Million
Q1 2018 Apr 23, 2018	BUY	$169.43 - $198.0 $331,743 - $387,684	1,958 Added 50.14%	5,863 $999,000
Q4 2017 Apr 23, 2018	BUY	$168.79 - $188.59 $659,124 - $736,443	3,905	3,905 $679,000

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whitener Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Whitener Capital Management, Inc. with notifications on news.

Account

Whitener Capital Management, Inc. Amgen Inc Transaction History